Elevated PARP1 polymerase in HER2+ breast cancer may confer susceptibility to PARP inhibitor drugs.
The UAB Comprehensive Cancer Center’s April 30 Fiesta Ball at Iron City will fund the work of UAB’s young cancer research scientists.
Hot topics in cancer prevention and control to be highlighted at national ASPO meeting hosted by UAB.
Renowned UAB HPV expert Warner Huh says new nine-valent HPV vaccine has the potential to eradicate the majority of cervical cancer.
Bartow Classic to benefit Coach Gene Bartow Fund for Cancer Research to be held 2 p.m. Saturday, Feb. 7.
BCRFA continues to provide substantial gifts to UAB Cancer Center to accelerate breast cancer research.
UAB neurology researcher Kristen Triebel gets substantial American Cancer Society grant to investigate the ability of patients to understand, choose and consent to treatment.
HPV testing alone is an effective alternative to current cervical cancer screening methods that use a Pap smear, or Pap smear-plus HPV test.
Ted J. Kaptchuk, professor of medicine at Harvard Medical School and director of the Harvard-wide Program in Placebo Studies and the Therapeutic Encounter at Beth Israel Deaconess Medical Center, will present “Placebo Effects: how is medicine more than drugs and surgery?” from noon – 1:00 p.m. on Tuesday, Jan. 13.
The UAB Cancer Center and Alabama State University receive $1.5 million NIH grant to create partnership and reduce cancer health disparities.